Marla C Dubinsky, MD
Professor of Pediatrics and Medicine, Icahn School of Medicine Mount Sinai New York
Chief, Pediatric GI and Nutrition, Mount Sinai Kravis Children’s Hospital
Co-Director, Susan and Leonard Feinstein IBD Clinical Center

Marla C. Dubinsky, MD, is a Professor of Pediatrics and Medicine at the Icahn School of Medicine at Mount Sinai, New York, NY. Dr. Dubinsky received her medical degree from Queen’s University, Canada. She completed her pediatric residency at Alberta Children’s Hospital, Calgary, Canada, and her clinical fellowship in gastroenterology and nutrition at Sainte-Justine Hospital at the University of Montreal, Canada. She completed her research fellowship in IBD at Cedars-Sinai Medical Center in Los Angeles, CA, where she served as the Director of the Pediatric IBD Center before going to Mount Sinai as the Chief of Pediatric Gastroenterology and Nutrition at the Mount Sinai Kravis Children’s Hospital and Co-Director of the Susan and Leonard Feinstein IBD Clinical Center. Dr. Dubinsky is also the Co-Director of the IBD Preconception and Pregnancy Planning Clinic at Mount Sinai. She is the Co-Founder of Mi-Test Health, and Cornerstones Health which is a non-profit organization dedicated to enhancing and transforming communication between health care providers, patients, and industry partners through creative, comprehensive, and expert-based educational program. She is also the Co-Founder of Trellus Health, a condition management digital health company leading with IBD. She is also a recipient of the 2022 Sherman Prize which is awarded to IBD researchers with extraordinary track records of achievement, making exceptional and pioneering contributions that transform IBD care and a recent recipient of the Jacobi Medallion at Mount Sinai Hospital.

Dr. Dubinsky has been engaged in inflammatory bowel disease (IBD) clinical and translational research for over two decades. She has a keen interest in personalized medicine in IBD and her research uncovers predictors of rapid disease progression with the goal of preventing complications by altering treatment plans. Dr. Dubinsky is the principal investigator of multiple large longitudinal cohorts including the Road to Prevention Multiplex Family Program at Mount Sinai with over 700 enrolled participants with a goal of using multi-omic data to predict the development of IBD in unaffected family members and co-investigator of the Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Progression in Children with Crohn’s Disease (RISK) study and senior author on the manuscript presenting a model to predict the natural history of pediatric Crohn’s disease. Dr. Dubinsky is very committed to women’s reproductive health in IBD and in addition to her research in this field she is the Co-founder of WECARE in IBD, an organization dedicated to the health of women with IBD. She is very committed to leading the next generation of female leaders in the field of GI. She has lectured widely, both nationally and internationally, and has published in more than 375 peer-reviewed journals, including New England Journal of Medicine, Gastroenterology, Lancet, JAMA, The Journal of Pediatric Gastroenterology and Nutrition, The Journal of Crohn’s and Colitis, Inflammatory Bowel Diseases, and the American Journal of Gastroenterology.

Zoë Gottlieb, MD
Assistant Professor of Medicine
Associate Director, Marie and Barry Lipman IBD Preconception and Pregnancy Planning Clinic
Henry D. Janowitz Division of Gastroenterology
Icahn School of Medicine at Mount Sinai

Dr. Gottlieb is an Assistant Professor of Medicine in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai and The Susan and Leonard Feinstein Inflammatory Bowel Disease Center, as well as the Associate Director of the Marie and Barry Lipman IBD Preconception and Pregnancy Planning Clinic (iPrePP) at Mount Sinai Hospital.

Board certified in Internal Medicine and Gastroenterology, Dr. Gottlieb specializes in the care of patients with IBD and is particularly focused on women's health in this population. Her clinical expertise and research center on fertility, preconception care, and pregnancy in women with ulcerative colitis and Crohn's disease. To this end, she is leading the Women with IBD and Motherhood (WIsDoM) study at Mount Sinai; this is the first prospective registry exploring factors impacting fertility in women with IBD. Dr. Gottlieb is a member of the American Gastroenterological Association, the American College of Gastroenterology, and the Crohn's and Colitis Foundation.

Education: Medical School: Harvard Medical School, Boston, MA, Residency: Massachusetts General Hospital, Boston, MA, Fellowship: Icahn School of Medicine at Mount Sinai Hospital, New York, NY

Jami Kinnucan-Brief Bio

Senior Associate Consultant, Division of Gastroenterology and Hepatology, Department of Medicine, Director of Intestinal Ultrasound, Gastroenterology Clinical Practice Chair, Co-Director of Digital Health and Practice Integration for Department of medicine.

Dr. Jami Kinnucan is an inflammatory bowel disease (IBD)specialist who joined the Mayo Clinic Florida practice in January 2021as a Senior Associate Consultant in the Division of Gastroenterology and Hepatology. Prior to Mayo Clinic she was an Assistant Professor of Medicine at Michigan Medicine. She currently serves as the Clinical Practice Chair for the Division of Gastroenterology & Hepatology and Co-Director for Digital Health and Practice Integration for the Department of Medicine. She is also the Director of the IBD Intestinal Ultrasound Program at Mayo Clinic Florida. She has been recognized as a fellow of the American College of Gastroenterology (ACG)and the American Gastroenterological Association (AGA). She is a former member of the ACG Board of Governors for the state of Michigan and Women’s Committee. She is active in the Crohn’s and Colitis Foundation and currently is the Co-Chair for the Women in IBD Task Force and member of the Government and Industry Affairs Committee for the National Scientific Advisory Committee. She is co-founder of the Michigan GI Society in 2020 and most recently founded the Florida Women in Gi organization. She serves as Associate Editor for the Crohn’s and Colitis 360 Journal. She is actively involved with research looking at impact of cannabis in IBD and received a 2024MayoSTARDOM award to evaluate the use of virtual reality on the impact of pain in patients with Crohn’s disease.

Education: University of Chicago-MD; University of Wisconsin-BS in Biology and Women’s Health

Sunanda V. Kane

Dr. Sunanda V. Kane is a Professor of Medicine at the Mayo Clinic in Rochester Minnesota. She has a busy clinical practice that reflects her expertise in inflammatory bowel disease (IBD), which is also the focus of her research work. Along with over 200 original research articles she just completed the third edition of a book for patients on self-management of IBD. She is a passionate teacher to patients in her previous role as Chair of the National Patient Education Committee for the Crohn’s and Colitis Foundation. She was the first female Associate Editor for Alimentary Pharmacology and Therapeutics. Amongst many leadership positions that she holds within Mayo Clinic is the Assistant Chair of Patient Experience within the Division of Gastroenterology and Hepatology, former Physician Chair of the Mayo Quality Academy Fellow Subcommittee and now she is the Chief Patient Experience Officer for the Mayo Enterprise; another highlight of Dr. Kane’s leadership journey was being President of the American College of Gastroenterology in 2018-2019.

Maria T. Abreu, MD

Professor of Medicine Professor of Microbiology and Immunology Director of the Crohn’s & Colitis Center University of Miami Miller School of Medicine President of the American Gastroenterological Association 2024

Dr. Maria T. Abreu is a physician-scientist and gastroenterologist who specializes in inflammatory bowel disease (IBD). She completed her medical degree at the University of Miami Miller School of Medicine (UMMSOM). Her postdoctoral training included an internship and residency in medicine at the Brigham and Women’s Hospital in Boston, Massachusetts, and a clinical and research fellowship in gastroenterology at the University of California, Los Angeles. Previously, she was an Associate Professor of Medicine at Mount Sinai School of Medicine, New York, and head of their IBD Center. She is currently the Director of the Crohn’s and Colitis Center at UMMSOM, where she is a Professor of Medicine and a Professor of Microbiology & Immunology. Dr. Abreu has more than 20 years of leadership experience in basic, translational, and clinical research and mentoring. She was elected to the American Society for Clinical Investigation in 2010; in 2018, she was elected to the Association of American Physicians (AAP). She completed a three-year term as Chair of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) in 2022. In 2019, she was elected Councilor-at-Large of the American Gastroenterological Association (AGA) Governing Board for a term of three years. Recently, she was inducted as the President of the AGA. She is the fifth woman and first Latina to hold this position. Dr. Abreu is a recipient of the 2019 Sherman Prize from the Bruce and Cynthia Sherman Charitable Foundation, which recognizes outstanding achievements in IBD. In 2020, she received the Mentoring Award from the Immunology, Microbiology, and Inflammatory Bowel Diseases (IMIBD) section of the AGA. In 2020, she was bestowed with Healio’s Lifetime Disruptor Award. This award goes to a gastroenterologist or hepatologist who consistently pushes the gastroenterology field forward through innovative treatments, practice management, patient care, or research. In 2023, Dr. Abreu received the Women Empowering and Embracing Women Award. She is the 30th alumni inducted into the UMMSOM Hall of Fame. Dr. Abreu is frequently invited as a speaker (in English and Spanish) at symposia on basic science and clinical topics all over the world. She has authored more than 200 peer-reviewed articles, books, chapters, and reviews.

Uma Mahadevan, MD
Lynne and Marc Benioff Professor of Gastroenterology
University of California, San Francisco
Director, UCSF Center for Colitis and Crohn's Disease
Website: IBD.UCSF.EDU
Twitter: @UmaMahadevanIBD

Dr. Uma Mahadevan is the Lynne and Marc Benioff Professor of Gastroenterology, Director of the Colitis and Crohn's Disease Center and Director of the Advanced IBD Fellowship at the University of California, San Francisco. She completed a medical degree at the State University of New York in Brooklyn, residency in internal medicine at Mount Sinai Medical Center in New York, Fellowship in gastroenterology at UCSF, and Advanced fellowship in IBD at the Mayo Clinic, Rochester, Minnesota. For her exceptional work in pregnancy and drug safety and her mentoring of GI fellows and junior faculty she received the AGA 2022 Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section Research Mentor Award and the 2022 Sherman Prize.

Dr. Mahadevan is a fellow of the American Gastroenterological Association, for whom she was Chair for the IMIBD Section, Chair of the AGA National IBD Parenthood initiative and Director (2023) and co-Director (2022, 2017) of the AGA Postgraduate Course. She is a Fellow of the American College of Gastroenterology and served on the Educational Affairs Committee and as a member of the Advanced IBD Fellow Curriculum Committee. She is an inaugural councilor on the ASGE Artificial Intelligence Institute for Gastroenterology. She was Chair of the Crohns Colitis Foundation Clinical Research Grants committee, a member of the National Scientific Advisory Committee and Taskforce on Women in IBD, and co-chair of the annual Crohn’s Colitis Congress (2020). Dr. Mahadevan is a member of the International Organization of IBD (IOIBD) for which she serves on the nominating committee.

Dr. Mahadevan is a global expert on the management of pregnancy and drug safety in the patient with IBD. She chairs the Helmsley Global Consensus on Management of Pregnancy in IBD (2024) and the joint AGA, Society of Maternal Fetal Medicine Clinical Care Pathway on the Management of IBD in Pregnancy (2019). She is interested in the role of diet and IBD and has an ongoing original study in this area. Her current projects include a national prospective registry of pregnancy outcomes and drug safety in women with IBD on immunosuppressive and biologic medications (PIANO) and a clinical trial on the impact of nutritional interventions in the management of IBD (SEAMUS). She has an interest in digital health and lead the transition of the GI Division to telemedicine at the start of the pandemic in March 2020, developed an IBD Chatbot with the Center for Digital Health and Innovation at UCSF, and the IBD Smartnote. Dr. Mahadevan has served on many prestigious journals, including special section editor for Gastroenterology. Dr. Mahadevan is proud to have mentored several Advanced IBD Fellows who now hold key roles in IBD Centers around the United States.

Sonia Friedman

Sonia Friedman, M.D. is the Chief of Gastroenterology at Tufts Medical Center and Professor of Medicine at Tufts University School of Medicine. She recently moved from Brigham and Women’s Hospital in Boston where she was a Professor of Medicine at Harvard Medical School. Dr. Friedman completed her undergraduate degree in biology at Stanford University and her MD at Yale Medical School. She did her medical internship and residency at University of Pennsylvania and her gastroenterology fellowship at Mount Sinai Medical Center in New York City. She has received national and international recognition for research and treatment of inflammatory bowel disease. Her research interests include reproductive health and the safety of medications taking during conception and pregnancy in patients with inflammatory bowel disease. Dr. Friedman is a frequent speaker and invited regional, national and international lecturer on the management of inflammatory bowel disease. She has authored or co-authored multiple peer-reviewed papers and is the Deputy Editor of the journal Inflammatory Bowel Diseases. She has received a recent Crohn’s and Colitis Foundation Senior Research Award as well as an American College of Gastroenterology Clinical Research Award to continue her work on reproductive health in inflammatory bowel disease.

Kim L. Isaacs, MD, PhD

Kim L. Isaacs MD, PhD, is an Associate Professor of Medicine at the University of North Carolina. Her clinical and research interests are management of complicated inflammatory bowel disease and clinical trials in inflammatory bowel disease. In addition, Dr. Isaacs is the GI Fellowship Director at the University of North Carolina.

Jane Elizabeth Onken, MD

Dr. Jane Onken is an Assistant Professor of Medicine Division of Gastroenterology, at Duke University Medical Center where she completed her medicine residency, served as Assistant Chief Resident and later completed a fellowship in gastroenterology.

Dr. Onken is the Director of the Inflammatory Bowel Disease Clinic at Duke University Medical Center. In 2001, she was awarded the Premier Physician Award by the Crohn's and Colitis Foundation of America. Dr. Onken received her medical degree from the George Washington University School of Medicine in Washington, DC. She serves on several professional committees and has had numerous articles and abstracts published in peer-reviewed journals.